Does Vidarabine Mediate Cardioprotection via Inhibition of AC5? - Wikidata - awgldk - TriplyDB

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

http://www.wikidata.org/entity/Q51648446

about

International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

P2860

Q39158851-ECCF6B18-B69B-4D67-83E1-138CC53C4009

P2860

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

http://www.wikidata.org/entity/Q51648446

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

@en

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

@nl

type

label

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

@en

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

@nl

prefLabel

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

@en

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

@nl

P1433

Q51648446-DD5CA7B3-1CC1-4C7F-93F1-7B62090BD99F

P1476

Q51648446-557DF414-DDC5-4570-9423-B0987DB4998E

P2093

Q51648446-959B28C8-AF18-4326-995E-F5A8074FE83E

P2860

Q51648446-0BCEBC98-B44C-42E3-8377-5B1768379A2D

Q51648446-29B277DC-50E0-431E-8BD6-7E4E30EE45D2

Q51648446-37300192-AF4F-430F-854A-A1E3F1C4292A

Q51648446-3FBD14ED-9176-4ADE-BA61-031C04FE3255

Q51648446-62414F31-4851-47A3-BE1B-972B3635E1FC

Q51648446-664D33BF-D903-44CF-9396-3981C529B015

Q51648446-7E4512ED-FF58-4238-ABA2-714FCEFA6594

Q51648446-909C43AE-985A-47AB-88E9-74FC9C26EF73

Q51648446-9EA32E2F-B416-4372-9E1E-12FF93A1DBD2

Q51648446-A6ED8282-11B9-40AB-AD32-03635B263959

P304

Q51648446-50AE1DE8-DEB1-4119-8939-5D856C1A7DE7

P31

Q51648446-A3EE1B37-4758-481F-BEC7-EE727896FD21

P356

Q51648446-1B6FCA0D-5A6D-475E-A827-DBA4D962D5D6

P407

Q51648446-CFD2674B-5C55-4514-A73E-C77503B6C37A

P433

Q51648446-A4981C44-DE91-48EF-85D0-CDDD743E0CC2

P478

Q51648446-231B9F4F-FE46-4AF9-B003-308AA8D0D274

P577

Q51648446-E34F6AE1-7526-4DCA-8FD9-2AC4B8A9FCC0

P698

Q51648446-E2203655-3861-4EB1-BA44-EA8FC744D423

P356

JPET.116.234245

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?

@en

P2093

Roland Seifert

http://www.w3.org/2001/XMLSchema#string

P2860

Similarly potent inhibition of adenylyl cyclase by P-site inhibitors in hearts from wild type and AC5 knockout mice

Motor dysfunction in type 5 adenylyl cyclase-null mice

Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds

Inhibitors of membranous adenylyl cyclases.

A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion.

Statistics in pharmacology.

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.

Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.

Vidarabine is neither a potent nor a selective AC5 inhibitor.

P304

242-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.116.234245

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

358

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27402379

http://www.w3.org/2001/XMLSchema#string